Hair dysmorphology in the R6/1 and R6/2 mouse models of Huntington's disease

Karolina Pierzynowska1, Magdalena Podlacha1, Dorota Łuszczek2

  • 1Department of Molecular Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland.

Gene
|September 8, 2020
PubMed

Insights

Huntington's disease (HD) mouse models, R6/1 and R6/2, exhibit previously undescribed hair abnormalities, including altered shape and increased diameter. This hair dysmorphology may serve as a novel, noninvasive marker for disease progression and therapeutic testing.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Animal Models

Background:

  • Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in the HTT gene.
  • While primarily neurodegenerative, HD affects peripheral tissues due to widespread HTT gene expression, leading to various symptoms.
  • R6/1 and R6/2 mouse lines are widely utilized models for studying HD phenotypes.

Purpose of the Study:

  • To identify and characterize novel phenotypic features in R6/1 and R6/2 Huntington's disease mouse models.
  • To investigate hair morphology as a potential noninvasive biomarker for HD in these established mouse models.

Main Methods:

  • Comparative analysis of hair morphology between R6/1 and R6/2 mice and control groups.
  • Utilized electron microscopy to assess detailed hair structure, including surface topography and scale integrity.
  • Measured hair diameter and evaluated pelage appearance.

Main Results:

  • Significant hair dysmorphology was observed in both R6/1 and R6/2 HD mouse models.
  • Hair diameter was significantly increased in HD models compared to controls.
  • Electron microscopy revealed altered hair surface (deep cavities, hilly texture, flattened appearance) and loosened scale structures.

Conclusions:

  • Hair morphology represents a novel, previously undescribed feature in R6/1 and R6/2 Huntington's disease mouse models.
  • Hair abnormalities, including shape and diameter changes, may serve as a simple, noninvasive marker for assessing HD progression.
  • This finding could be valuable for evaluating the efficacy of potential therapeutics in preclinical HD research using these mouse models.

Related Concept Videos